Beesan Tan

Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection

Beesan Tan, Nicholas Opoku, Simon K. Attah et al. · PLoS neglected tropical diseases · 2022 · 155 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

<scp>PF</scp>‐04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo‐Controlled Study

Robert J Charnigo, David Beidler, Denis Rybin et al. · Clinical and Translational Science · 2018 · 34 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Discovery of Efficacious <i>Pseudomonas aeruginosa</i>-Targeted Siderophore-Conjugated Monocarbams by Application of a Semi-mechanistic Pharmacokinetic/Pharmacodynamic Model

Kerry E. Murphy-Benenato, Pratik Bhagunde, April Chen et al. · Journal of Medicinal Chemistry · 2015 · 27 citations

Medicine, Medicinal Chemistry, Pharmacology +17

A 4-week study assessing the pharmacokinetics, pharmacodynamics, safety, and tolerability of the glucagon receptor antagonist PF-06291874 administered as monotherapy in subjects with type 2 diabetes mellitus

Arthur Bergman, Beesan Tan, Veena Somayaji et al. · Diabetes Research and Clinical Practice · 2017 · 25 citations

Medicine, Pharmacokinetics, Pharmacology +15

Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects

Beesan Tan, Himanshu Naik, In‐Jin Jang et al. · Malaria Journal · 2009 · 24 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +14